GLASF
Price
$5.41
Change
-$0.21 (-3.74%)
Updated
Nov 18 closing price
Capitalization
436.61M
Intraday BUY SELL Signals
OPTHF
Price
$0.26
Change
-$0.00 (-0.00%)
Updated
Nov 18 closing price
Capitalization
26.59M
Intraday BUY SELL Signals
Interact to see
Advertisement

GLASF vs OPTHF

Header iconGLASF vs OPTHF Comparison
Open Charts GLASF vs OPTHFBanner chart's image
Glass House Brands
Price$5.41
Change-$0.21 (-3.74%)
Volume$204.05K
Capitalization436.61M
OPTIMI HEALTH
Price$0.26
Change-$0.00 (-0.00%)
Volume$500
Capitalization26.59M
GLASF vs OPTHF Comparison Chart in %
GLASF
Daily Signal:
Gain/Loss:
OPTHF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLASF vs. OPTHF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Hold and OPTHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (GLASF: $5.41 vs. OPTHF: $0.26)
Brand notoriety: GLASF and OPTHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GLASF: 111% vs. OPTHF: 1%
Market capitalization -- GLASF: $436.61M vs. OPTHF: $26.59M
GLASF [@Pharmaceuticals: Generic] is valued at $436.61M. OPTHF’s [@Pharmaceuticals: Generic] market capitalization is $26.59M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLASF’s FA Score shows that 0 FA rating(s) are green whileOPTHF’s FA Score has 0 green FA rating(s).

  • GLASF’s FA Score: 0 green, 5 red.
  • OPTHF’s FA Score: 0 green, 5 red.
According to our system of comparison, OPTHF is a better buy in the long-term than GLASF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLASF’s TA Score shows that 4 TA indicator(s) are bullish while OPTHF’s TA Score has 4 bullish TA indicator(s).

  • GLASF’s TA Score: 4 bullish, 6 bearish.
  • OPTHF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, OPTHF is a better buy in the short-term than GLASF.

Price Growth

GLASF (@Pharmaceuticals: Generic) experienced а -25.38% price change this week, while OPTHF (@Pharmaceuticals: Generic) price change was +9.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.77%. For the same industry, the average monthly price growth was -6.55%, and the average quarterly price growth was +28.28%.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.77% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLASF($437M) has a higher market cap than OPTHF($26.6M). OPTHF YTD gains are higher at: 75.125 vs. GLASF (-8.471). GLASF has higher annual earnings (EBITDA): 49M vs. OPTHF (-3.42M). GLASF has more cash in the bank: 40.7M vs. OPTHF (55.7K). OPTHF has less debt than GLASF: OPTHF (2.83M) vs GLASF (72.8M). GLASF has higher revenues than OPTHF: GLASF (222M) vs OPTHF (496K).
GLASFOPTHFGLASF / OPTHF
Capitalization437M26.6M1,643%
EBITDA49M-3.42M-1,433%
Gain YTD-8.47175.125-11%
P/E Ratio513.07N/A-
Revenue222M496K44,758%
Total Cash40.7M55.7K73,070%
Total Debt72.8M2.83M2,573%
FUNDAMENTALS RATINGS
GLASF: Fundamental Ratings
GLASF
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLASFOPTHF
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 14 days ago
89%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLASF
Daily Signal:
Gain/Loss:
OPTHF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VNVCX21.450.11
+0.52%
Natixis Vaughan Nelson Mid Cap C
AZMCX19.91N/A
N/A
Virtus NFJ Emerging Markets Value C
GACIX44.57N/A
N/A
Gabelli Small Cap Growth I
TILPX32.07N/A
N/A
Nuveen Large Cap Growth Premier
REBYX25.90-0.04
-0.15%
Russell Inv US Small Cap Equity Y

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
-1.87%
TSNDF - GLASF
63%
Loosely correlated
-3.48%
GTBIF - GLASF
62%
Loosely correlated
-4.06%
TCNNF - GLASF
60%
Loosely correlated
-8.46%
CURLF - GLASF
57%
Loosely correlated
-2.10%
CRLBF - GLASF
57%
Loosely correlated
-11.60%
More

OPTHF and

Correlation & Price change

A.I.dvisor tells us that OPTHF and ESAIY have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPTHF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPTHF
1D Price
Change %
OPTHF100%
+7.50%
ESAIY - OPTHF
20%
Poorly correlated
+2.05%
SHIEF - OPTHF
6%
Poorly correlated
N/A
GLASF - OPTHF
5%
Poorly correlated
-1.87%
IMCC - OPTHF
3%
Poorly correlated
-1.87%
SEHCF - OPTHF
2%
Poorly correlated
N/A
More